SCHEMBL6537779

SCHEMBL6537779

CC(C)OCc1cnc2c([N+](=O)[O-])cccc2c1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.48
ALDH1A1 P00352 6/20 0.48
MEN1 O00255 5/20 0.48
TDP1 Q9NUW8 3/20 0.48
KDM4E B2RXH2 3/20 0.48
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
PIN1 Q13526 2/20 0.38
MAPT P10636 5/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
HTT P42858 2/20 0.38
MITF O75030 1/20 0.38
PDE10A Q9Y233 1/20 0.37
CYP2D6 P10635 2/20 0.36
CYP2C19 P33261 2/20 0.36
MAPK1 P28482 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537614 0.86 KMT2A (0.51) KMT2AALDH1A1MEN1TDP1KDM4E
SCHEMBL6538075 0.84 KMT2A (0.49) KMT2AALDH1A1MEN1TDP1KDM4E
SCHEMBL6538024 0.80 G6PD (0.38) KMT2AMEN1TDP1KDM4EMAPT
SCHEMBL6537817 0.79 ALDH1A1 (0.51) KMT2AALDH1A1MEN1TDP1KDM4E
SCHEMBL6537647 0.77 ALDH1A1 (0.42) KMT2AALDH1A1MEN1TDP1KDM4E
SCHEMBL6537329 0.76 KMT2A (0.51) KMT2AALDH1A1MEN1TDP1KDM4E
SCHEMBL6537483 0.74 ALDH1A1 (0.59) KMT2AALDH1A1MEN1TDP1KDM4E
SCHEMBL6537368 0.74 ALDH1A1 (0.67) KMT2AALDH1A1MEN1TDP1KDM4E
SCHEMBL6537393 0.73 MEN1 (0.54) KMT2AALDH1A1MEN1TDP1KDM4E
SCHEMBL1818771 0.72 ALDH1A1 (0.53) KMT2AALDH1A1MEN1TDP1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed